Login Register Cart 0
Generic placeholder image

Nanoscience & Nanotechnology-Asia

Editor-in-Chief

ISSN (Print): 2210-6812
ISSN (Online): 2210-6820

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Etoricoxib and Herbal Adjuvant Containing Nanoparticles Incorporated Gel and Ointment Formulations for the Treatment of Human Skin Melanoma (SK-MEL-2)

Author(s): Rashmi Sharma and Rishabha Malviya*

Volume 11, Issue 3, 2021

Published on: 09 May, 2020

Page: [339 - 349] Pages: 11

DOI: 10.2174/2210681210999200509233724

Price: $65

Abstract

Aim: The aim of the study was to develop nanoparticles consisting of etoricoxib with ethanolic extract of ginger rhizome (GE) and basil leaves (BE) and evaluate against human skin cancer cells (melanoma, SK-MEL-2). Nanoparticles were further incorporated into gel and ointment and characterized.

Methods: Concentration of extract was varied while etoricoxib remained constant in nanoparticles. Nanoparticles were incorporated into gel and ointment, prepared by using tamarind seed polysaccharide and aloe vera gel, respectively.

Results: All the batches of nanoparticles were evaluated for particle size and were found from 924 nm (N1) to 1084 nm (N9). The loading efficiency of etoricoxib varied form 66.8 ± 0.05% (N4) to 85.1 ± 0.04% (N9), for GE 60.3 ± 0.04% (N4) to 72.1 ± 0.05% (N9), for BE 59.5 ± 0.04% (N8) to 80.5 ± 0.03% (N9). The consistency of ointment and gel was found smooth. The pH of the nanoparticles incorporated ointment was observed 6.2 ± 0.023 (O6) to 6.2 ± 0.089 (O4), viscosity was found as 0.70 ± 0.098 (O3) to 1.130 ± 0.092 (O1) gm/cm3, and spreadability in the range of 58.3 ± 0.062 (O2) to 66.2 ± 0.098 (O5)%. The pH of nanoparticles incorporated gel was observed 6.2 ± 0.019 (G2) to 6.2 ± 0.098 (G7), viscosity was found as 0.847 ± 0.030 (G7) to 1.130 ± 0.065 gm/cm3 (G9), with spreadability in the range of 62.5 ± 0.045% (G5) to 70.51±0.056% (G4). In vitro cytotoxic studies showed that nanoparticles incorporated gel formulation (G1) was able to control cell growth (SK-MEL-2).

Conclusion: It can be concluded that etoricoxib and herbal components consisting of formulations were able to control the growth of human skin cancer cells.

Keywords: Nanoparticles, gel formulation, herbal adjuvant, skin cancer, etoricoxib, nucleation.

Graphical Abstract

[1]
Savjani, K.T.; Gajjar, A.K.; Savjani, J.K. Drug solubility: Importance and enhancement techniques. ISRN Pharm., 2012, 2012, 195727.
[http://dx.doi.org/10.5402/2012/195727] [PMID: 22830056]
[2]
Sareen, S.; Mathew, G.; Joseph, L. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int. J. Pharm. Investig., 2012, 2(1), 12-17.
[http://dx.doi.org/10.4103/2230-973X.96921] [PMID: 23071955]
[3]
Thorat, A.A.; Dalvi, S.V. Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: Recent developments and future perspective. Chem. Eng. J., 2012, 181, 1-34.
[http://dx.doi.org/10.1016/j.cej.2011.12.044]
[4]
Mullin, J.W.; Nyvlt, J. Programmed cooling of batch crystallizers. Chem. Eng. Sci., 1971, 26(3), 369-377.
[http://dx.doi.org/10.1016/0009-2509(71)83012-9]
[5]
Rundhaug, J.E.; Fischer, S.M. Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis. Photochem. Photobiol., 2008, 84(2), 322-329.
[http://dx.doi.org/10.1111/j.1751-1097.2007.00261.x] [PMID: 18194346]
[6]
Howe, L.R.; Dannenberg, A.J. A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer. Semin. Oncol., 2002, 29(Suppl. 11), 111-119.
[http://dx.doi.org/10.1016/S0093-7754(02)70134-6] [PMID: 12138405]
[7]
Singh, B.; Lucci, A. Role of cyclooxygenase-2 in breast cancer. J. Surg. Res., 2002, 108(1), 173-179.
[http://dx.doi.org/10.1006/jsre.2002.6532] [PMID: 12472107]
[8]
Malviya, R.; Sharma, P.K.; Dubey, S.K. Stability facilitation of nanoparticles prepared by ultrasound assisted solvent-antisolvent method: Effect of neem gum, acrylamide grafted neem gum and carboxymethylated neem gum over size, morphology and drug release. Mater. Sci. Eng. C, 2018, 91, 772-784.
[http://dx.doi.org/10.1016/j.msec.2018.06.013] [PMID: 30033312]
[9]
Ciofani, G.; Riggio, C.; Raffa, V.; Menciassi, A.; Cuschieri, A. A bi-modal approach against cancer: Magnetic alginate nanoparticles for combined chemotherapy and hyperthermia. Med. Hypotheses, 2009, 73(1), 80-82.
[http://dx.doi.org/10.1016/j.mehy.2009.01.031] [PMID: 19272717]
[10]
Mascolo, N.; Jain, R.; Jain, S.C.; Capasso, F. Ethnopharmacologic investigation of ginger (Zingiber officinale). J. Ethnopharmacol., 1989, 27(1-2), 129-140.
[http://dx.doi.org/10.1016/0378-8741(89)90085-8] [PMID: 2615416]
[11]
Ghayur, M.N.; Gilani, A.H. Ginger lowers blood pressure through blockade of voltage-dependent calcium channels. J. Cardiovasc. Pharmacol., 2005, 45(1), 74-80.
[http://dx.doi.org/10.1097/00005344-200501000-00013] [PMID: 15613983]
[12]
Sultana, S.; Ali, M. Chemical composition of volatile oil of the rhizome of Zingiber officinale roscoe and its antimicrobial activity. World J. Pharm. Pharm. Sci., 2015, 4, 741-752.
[13]
Malviya, R.; Sharma, P.K.; Sharma, R. Topical anti-inflammatory ointment formulation and a method of preparation thereof. Application No.201911038394 A, 2019.
[14]
Vishakha, W.; Ravindranath, S. Formulation development and evaluation of ph triggered in situ ophthalmic gel of besifloxacin hydrochloride. J. Drug Deliv. Ther., 2018, 8(5), 313-321.
[http://dx.doi.org/10.22270/jddt.v8i5.1874]
[15]
Desai, P.; Mhaskar, G.M. Formulation and evaluation of Zingiber officinale emulgel. Res. J. Pharm. and Tech., 2019, 12(3), 1294-1300.
[http://dx.doi.org/10.5958/0974-360X.2019.00217.8]
[16]
Agarwal, H.; Malviya, R.; Sharma, P.K. Evaluation of in situ gel forming system loaded with etoricoxib and herbal adjuvant nanoparticles against human colon cancer cell lines (HT-29). Lett. Appl. NanoBioSci., 2020, 9(1), 789-795.
[http://dx.doi.org/10.33263/LIANBS0091.789795]
[17]
Malviya, R.; Sharma, P.K.; Dubey, S.K. Efficiency of Self Assembled Etoricoxib Containing Polyelectrolyte Complex Stabilized Cubic Nanoparticles against Human Cancer Cells; Precision Medical Sciences, 2020. [Epub ahead of print].
[18]
Jones, A.G.; Mullin, J.W. Programmed cooling crystallization of potassium sulphate solutions. Chem. Eng. Sci., 1974, 29(1), 105-118.
[http://dx.doi.org/10.1016/0009-2509(74)85036-0]
[19]
Dirksen, J.A.; Ring, T.A. Fundamentals of crystallization: kinetic effects on particle size distributions and morphology. Chem. Eng. Sci., 1991, 46(10), 2389-2427.
[http://dx.doi.org/10.1016/0009-2509(91)80035-W]
[20]
Sugimoto, T. Formation of monodispersednano‐and micro‐particles controlled in size, shape, and internal structure. Chem. Eng. Technol., 2003, 26(3), 313-321.
[21]
Sohnel, O.; Garside, J. Precipitation: Basic principles and industrial applications; Butterworth-Heinemann: Boston, 1992.
[22]
Molina, M.; Asadian-Birjand, M.; Balach, J.; Bergueiro, J.; Miceli, E.; Calderón, M. Stimuli-responsive nanogel composites and their application in nanomedicine. Chem. Soc. Rev., 2015, 44(17), 6161-6186.
[http://dx.doi.org/10.1039/C5CS00199D] [PMID: 26505057]
[23]
Vasava, S.S.; Chotai, N.P.; Patel, H.K. Formulation and evaluation of nanosuspension drug delivery system of etoricoxib. Pharm. Sci., 2015, 6(1), 10-27.
[24]
Kesharwani, R.; Sachan, A.; Singh, S.; Patel, D. Formulation and evaluation of solid lipid nanoparticle (SLN) based topical gel of etoricoxib. J. Appl. Pharm. Sci., 2016, 6(10), 124-131.
[http://dx.doi.org/10.7324/JAPS.2016.601017]
[25]
Bilthariya, U.; Jain, N.; Rajoriya, V.; Jain, A.K. Folate-conjugated albumin nanoparticles for rheumatoid arthritis-targeted delivery of etoricoxib. Drug Dev. Ind. Pharm., 2015, 41(1), 95-104.
[http://dx.doi.org/10.3109/03639045.2013.850705] [PMID: 24164469]
[26]
Bharadwaj, R.; Das, P.J.; Pal, P.; Mazumder, B. Topical delivery of paclitaxel for treatment of skin cancer. Drug Dev. Ind. Pharm., 2016, 42(9), 1482-1494.
[http://dx.doi.org/10.3109/03639045.2016.1151028] [PMID: 26850463]
[27]
Local treatments other than surgery for basal and squamous cell skin cancers., Available from: https://www.cancer.org/cancer/basal-and-squamous-cell-skin-cancer/treating/other-than-surgery.html (Accessed on: 09 April 2020).

Rights & Permissions Print Cite
Article Metrics
5
2
© 2024 Bentham Science Publishers | Privacy Policy